Capital 10X President Evan Veryard sits down with Khiron Life Sciences
They discuss Khiron’s Colombian operations, expansion plans, and whether Khiron is on track to meet analyst expectations.
The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Capital 10X hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.